1 active not recruiting, 1 completed, 1 recruiting. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
Follow Immunoglobulin A Nephropathy: new trials by email Literature Review of Immunoglobulin A Nephropathy trials Research Report on Immunoglobulin A Nephropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy. MIL116, Matching Placebo - Immunoglobulin A Nephropathy | Phase 1 / Phase 2 | Recruiting | Beijing Mabworks Biotech Co., Ltd. | 130 | 2026-02-05 | 2026-04-13 |
| An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases Povetacicept - Lupus Nephritis, Immunoglobulin A Nephropathy | Phase 1 / Phase 2 | Active not recruiting | Alpine Immune Sciences, Inc. | 72 | 2023-03-15 | 2026-10-20 |
| First in Human Study to Assess Safety of VIS649 in Healthy Subjects VIS649, Placebo - Immunoglobulin A Nephropathy, IgAN - IgA Nephropathy | Phase 1 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 51 | 2018-10-09 | 2026-05-01 |
Glomerulonephritis, IGA (3) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Churg-Strauss Syndrome (1) · Glomerulonephritis, Membranous (1) · Granulomatosis with Polyangiitis (1) · Lupus Nephritis (1) · Microscopic Polyangiitis (1)
Autoimmune Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Glomerulonephritis (3) · Immune System Diseases (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Nephritis (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebral Small Vessel Diseases (1) · Cerebrovascular Disorders (1)
Alpine Immune Sciences, Inc. (1) · Beijing Mabworks Biotech Co., Ltd. (1) · Otsuka Pharmaceutical Development & Commercialization, Inc. (1)
United States (2) · Australia (1) · China (1) · Puerto Rico (1) · South Korea (1)
Esther Yoon, MD (1)